Medite Cancer Diagnostics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
923.00
699.00
859.00
2,163.00
6,811.00
Depreciation, Depletion & Amortization
74.00
170.00
177.00
214.00
293.00
Other Funds
190.00
2.00
-
729.00
1,553.00
Funds from Operations
1,039.00
447.00
604.00
1,220.00
4,473.00
Changes in Working Capital
541.00
444.00
216.00
129.00
1,888.00
Net Operating Cash Flow
498.00
891.00
388.00
1,091.00
2,585.00
Capital Expenditures
-
463.00
354.00
115.00
134.00
Sale of Fixed Assets & Businesses
-
1.00
-
-
-
Net Investing Cash Flow
-
462.00
354.00
115.00
134.00
Issuance/Reduction of Debt, Net
160.00
172.00
342.00
294.00
1,538.00
Net Financing Cash Flow
460.00
1,704.00
1,712.00
700.00
3,882.00
Net Change in Cash
38.00
155.00
357.00
479.00
382.00
Free Cash Flow
498.00
1,354.00
596.00
1,206.00
2,719.00
Deferred Taxes & Investment Tax Credit
-
80.00
78.00
-
492.00
Change in Capital Stock
300.00
1,876.00
2,054.00
406.00
2,344.00
Exchange Rate Effect
-
196.00
613.00
27.00
203.00
Miscellaneous Funds
-
-
-
-
984.00
About Medite Cancer Diagnostics
View Profile
